THOMAS GIORDANO to HIV-1
This is a "connection" page, showing publications THOMAS GIORDANO has written about HIV-1.
Connection Strength
0.801
-
Time above 1500 copies: a viral load measure for assessing transmission risk of HIV-positive patients in care. AIDS. 2015 May 15; 29(8):947-54.
Score: 0.371
-
Clinical Utility of the Signal-to-Cutoff Ratio of Reactive HIV Antigen/Antibody Screening Tests in Guiding Emergency Physician Management. J Acquir Immune Defic Syndr. 2022 03 01; 89(3):332-339.
Score: 0.149
-
Validity of self-report measures in assessing antiretroviral adherence of newly diagnosed, HAART-na?ve, HIV patients. HIV Clin Trials. 2011 Sep-Oct; 12(5):244-54.
Score: 0.072
-
Transmitted HIV-1 drug resistance among young men of color who have sex with men: a multicenter cohort analysis. J Adolesc Health. 2011 Jan; 48(1):94-9.
Score: 0.067
-
Predictors of reincarceration and disease progression among released HIV-infected inmates. AIDS Patient Care STDS. 2010 Jun; 24(6):389-94.
Score: 0.066
-
Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trial. AIDS Patient Care STDS. 2010 May; 24(5):287-95.
Score: 0.065
-
Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy. AIDS. 2005 Mar 04; 19(4):399-406.
Score: 0.011